Stat3 upregulates leucine-rich repeat-containing g protein-coupled receptor 4 expression in osteosarcoma cells

Jia Liu1, Wei Wei2, Chang-An Guo1

  • 1Department of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Insights

Signal transducer and activator of transcription 3 (Stat3) promotes leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4) expression in osteosarcoma. This Stat3-LGR4 network may drive cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Signal transducer and activator of transcription 3 (Stat3) activation is a common feature in human cancers.
  • Osteosarcoma is a prevalent bone cancer where Stat3 signaling is frequently implicated.

Purpose of the Study:

  • To investigate the relationship between Stat3 signaling and gene expression in osteosarcoma.
  • To identify novel transcriptional targets of Stat3 in osteosarcoma cells.

Main Methods:

  • PCR-based microarrays were employed using cDNA from interleukin-6 (IL-6) treated osteosarcoma cells.
  • Small interfering RNA (siRNA) was used to assess the effect of Stat3 deficiency on gene expression.
  • Bioinformatic analysis identified a Stat3 binding motif in the LGR4 promoter region.

Main Results:

  • Leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4) was identified as a transcriptional target of Stat3.
  • Stat3 overexpression enhanced LGR4 expression, while Stat3 deficiency reduced it.
  • A functional Stat3 binding motif was confirmed in the LGR4 promoter (-556 to -549 bp).

Conclusions:

  • A novel molecular network involving Stat3 and LGR4 in osteosarcoma has been elucidated.
  • This Stat3-LGR4 interaction is a potential regulator of osteosarcoma development and progression.